期刊文献+

固尔苏治疗新生儿呼吸窘迫综合征影响因素分析 被引量:3

Factors Analysis on Neonatal Respiratory Distress Syndrome with Pulmonary Surfactant
下载PDF
导出
摘要 目的:分析可能影响固尔苏治疗新生儿呼吸窘迫综合征的因素,为临床治疗评估提供参考。方法:回顾性收集应用固尔苏治疗新生儿呼吸窘迫综合征的130例患儿资料,记录性别、孕周、体重、Apgar评分、体位、剂量、使用固尔苏时间、血红蛋白、pH值等指标,应用多因素回归分析了解其可能的影响因素。结果:经多因素回归分析,孕周、体重、pH值、剂量等指标,经检验有统计学意义(P<0.05)。结论:孕周短、体重低、pH值低及剂量少可能是影响固尔苏治疗新生儿呼吸窘迫综合征的因素,临床应特别注意,以提高显效率,降低医疗风险。 Objective: Analyze factors which may affect Pulmonary surfactant in the treatment of neonatal respiratory distress syn- drome, provide a reference basis for clinical treatment evaluation. Methods :130 cases who used Pulmonary surfactant to treat the neonatal respiratory distress syndrome in our pediatric hospital were collected; Record gender, gestational age, weight, and Apgar score, postures, dose, use Pulmonary surfactant time, hemoglobin, PH value,a total of nine indicators, the application of multiple factors regression analysis was applied to understand the possible influencing factors. Results:The multi-factor regression analysis, gestational weeks, weight, pH value, dose the inspection were statistically significant (P%0.05). Conclusion : Short that gestational weeks,low weight, pH value and low dose may be less influential Pulmonary surfactant in the treatment of neonatal respiratory distress syndrome factor, clinical special attention should be taken to these indicators, in order to improve efficiency and reduce the medical risk.
出处 《亚太传统医药》 2013年第5期148-149,共2页 Asia-Pacific Traditional Medicine
关键词 固尔苏 新生儿呼吸窘迫综合征 疗效 因素 Pulmonary Surfactant Neonatal Respiratory Distress Syndrome Curative Effect Factors
  • 相关文献

参考文献5

二级参考文献20

  • 1王莹,马雅玲,张巍.肺表面活性物质预防早产儿RDS的临床观察[J].新生儿科杂志,2004,19(4):148-151. 被引量:27
  • 2刘棋明,曹南华,胡春芳,曹爱华.固尔苏预防早产儿呼吸窘迫综合征的临床观察[J].儿科药学杂志,2005,11(3):42-44. 被引量:11
  • 3柳洁,王莉,孙健梅.固尔苏预防早产儿呼吸窘迫综合征的临床研究[J].中国新生儿科杂志,2007,22(3):139-141. 被引量:40
  • 4金汉珍.实用新生儿学[M].第3版.北京:人民卫生出版社[J] ,2007:268,305-307.
  • 5Stevens TP,Blennow M,Soll RF.Early surfactant administration with brief ventilation vs.selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.Cochrane Database Syst Rev,2002,CD003063.
  • 6Halliday HL,Tamow-Mordi WO,Corcoran JD,et al.Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory disress syndrome.Arch DisChild,1993,276-280.
  • 7Couser RJ,Ferrara TB,Wheeler W,et al.Pulmonary follow-up 2.5 years after a randomized,controlled,multiple dose bovine surfactant study of preterm newborn infants.Pediatr Pulmonal,1993,15:163-167.
  • 8Soll RF.Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.Cochrane Database Syst Rev,2000:CD000511.
  • 9Kattwinkel J,Bloom BT,Delmore P,et al.High-Versus Low-Thredshold Surfactant Retreatment For Neonatal Respiratory Dis-tress Syndrome[J].Pediatrics,2000,106(2):282-288
  • 10李锐.固尔苏治疗新生儿呼吸窘迫综合征护理研究[J].全科护理,2009,7(22):2047-2048. 被引量:5

共引文献76

同被引文献36

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部